Indonesia Outbound Medical Travel in 2026

Indonesia remains one of the largest source markets for medical travel in Asia. Patients travel mainly for oncology, cardiac surgery and complex diagnostics, often after long domestic waiting times. Malaysia and Singapore hold the largest share, but China is gaining ground on cost and on the availability of advanced imaging and proton therapy. Language and halal food provision are decisive factors for Indonesian families choosing a destination.